Our scientific advisory board

Scientific Advisory Board

Pancreatic Cancer UK has a Scientific Advisory Board (SAB) with a strong international membership to ensure that funds raised will be spent as effectively as possible.

SAB Chair:


Professor Michelle Garrett, Professor of Cancer Therapeutics, University of Kent, UK, 2021-present

A number of distinguished international experts in the field also serve as members of the Board:


  • Professor Juan Valle, Professor in Medical Oncology, University of Manchester, UK, 2016-present
  • Professor Margaret Tempero, Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco, USA, 2016-present
  • Professor Rajesh Chopra, Venture Partner, Apple Tree Partners, UK, 2017-present
  • Dr Julie Guillermet-Guibert, Team Leader, INSERM, Toulouse, France, 2017-present
  • Professor Tony Hollingsworth, Associate Director for Basic Research, University of Nebraska, USA, 2017-present
  • Dr Raghu Kalluri, Professor and Chair, MD Anderson Cancer Centre, Texas USA, 2017-present
  • Professor Ilse Rooman, Professor, Vrije Universiteit, Belgium, 2017-present
  • Professor Anirban Maitra, Professor of Pathology and Translational Molecular Pathology, MD Anderson Cancer Centre, Texas USA, 2021-present
  • Professor Paula Ghaneh, Professor of Surgery and Senior Lecturer, University of Liverpool, UK, 2021-present
  • Professor Dieter Saur, Gastroenterologist and Oncologist, Technical University of Munich, Germany, 2021-present
  • Professor Maria Hawkins, Professor of Radiation Oncology, University College London, UK, 2021-present
  • Mr Richard Jackson, Medical Statistician, University of Liverpool, UK, 2021-present
  • Dr Gina DeNicola, Assistant Member, Department of Cancer Physiology, Moffitt Cancer Centre, Florida, US, 2021-present
  • Dr Stephanie Dougan, Assistant Professor, Microbiology and Immunobiology, Dana Farber Cancer Institute, Boston, US, 2021-present
  • Dr Seth Coffelt, Junior Group Leader, CRUK Beatson Institute, Glasgow, UK, guest member 2021-22
  • Professor Sam Ahmedzai, Head of the Academic Unit of Supportive Care and co-chair of the Living With and Beyond Cancer NCRI Research Group , University of Sheffield, Sheffield, UK, guest member 2021-22

SAB lay members:


  • Roy Bowdery, UK, 2018-present
  • Michael Stead, UK, 2018-present
  • Claire Hopkins, UK, 2021- present
  • Angela Donkin, UK, 2021- present

As part of the scientific review process, the Board provides expert advice to the CEO and Trustees on:

  • Development of the charity’s research strategy and grant giving programme
  • External referees for applications (‘peer reviewers’)
  • Assessment of and final recommendations on applications

The SAB also provides advice and support for the charity on reporting and dissemination of research results.

Previous SAB members:


  • Professor David Tuveson, Director of the Cold Spring Harbor Laboratory, New York, USA, 2010-2016
  • Professor Aldo Scarpa, Università di Verona, Italy, 2010-2017
  • Dr Kyoichi Takaori, Kyoto University, Graduate School of Medicine, Kyoto, Japan, 2013-2017
  • Professor Jim Abbruzzese, Chief of the Division of Medical Oncology and Associate Director for Clinical Research, Duke University, North Carolina, USA, 2010-2019
  • Professor Andrew Biankin, Regius Chair of Surgery/Director of Translational Research Centre, Wolfson Wohl Cancer Research Centre, University of Glasgow, UK, 2010-2019
  • Professor Helmut Friess, Department of Surgery, Technische Universität München, Germany, 2010-2019
  • Professor Francisco Real, Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain, 2010-2019
  • Professor Eithne Costello, Pancreas Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK, 2013-2019
  • Professor Nick Lemoine, Director of the Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, University of London, UK, 2013-2019
  • Professor Kenneth Hess, Professor of Biostatistics, MD Andersor Cancer Centre, Texas USA, 2017-2019
  • John Nathan, Lay Member, UK, 2014-2017
  • Catherine McGrath, Lay Member, UK, 2014-2017
  • Dr Anna Gerring, Lay Member, UK, 2018-2019
  • Professor Carl Borrebaeck, Professor at Department of Immunotechnolgy, Lund University, Sweden, 2017-2020
  • Professor Douglas Fearon, Professor, Cold Spring Harbor Laboratory, USA and University of Cambridge, UK, 2016-2020
  • Professor Gillies McKenna, Head of the Department of Oncology, University of Oxford, UK, 2016-2020
  • Professor Daniel Palmer-North West Cancer Research Fund Professor and Honorary Consultant in Medical Oncology, University of Liverpool, UK, Guest member for 2019-20
  • Katerina Georgiadis, Lay member, UK, 2018-2019
  • Zoë Buckley, Lay member, UK, 2018-2020
  • Stuart McWilliam, UK, 2021

Clinical Pioneer Award Review Panel 2019-20

Chair:


Professor Stephen Smith, Chair of the Scientific Advisory Board, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

Panel members:


  • Vicki Stevenson-Hornby, Macmillan HPB Specialist Nurse, Wigan and Leigh Foundation Trust, UK
  • Professor Giuseppe Kito Fusai, Consultant General HPB Surgeon, Royal Free Hospital, UK
  • Dr Naureen Starling, Consultant Medical Oncologist, The Royal Marsden, UK
  • Oonagh Griffin, Senior Pancreatic Dietician, Trinity College Dublin
  • Ilaria Mirabile, Transformation Lead (Innovation, Treatment and Care), NHS Cancer Programme, NHS England and NHS Improvement, UK
  • Cath Miller, Project Nurse, Leeds Teaching Hospitals NHS Trust, UK
  • Lesley Goodburn, Lay Member, UK
  • Claire Hopkins, Lay Member, UK

Conflicts of Interest Policy

Pancreatic Cancer UK has a rigorous policy on conflicts of interest in relation to both external peer reviewers and members of the SAB. Note that an important part of this policy is that the Chair or Vice Chair will withdraw from the entire research grants round if it includes any applications from members of his own research team.